Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?

B Ola; M Afnan; K Sharif; N Hammadieh; S Papaioannou; A Coomarasamy

Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?

B Ola, M Afnan, K Sharif, N Hammadieh, S Papaioannou, A Coomarasamy

Birmingham Medical School

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	1141-2
Number of pages	2
Journal	Acta obstetricia et gynecologica Scandinavica
Volume	80
Issue number	12
Publication status	Published - Dec 2001

Keywords

Adult
Cost-Benefit Analysis
Drug Costs
Female
Fertilization in Vitro
Follicle Stimulating Hormone
Humans
Recombinant Proteins

Cite this

@article{1f36f2e51a654073accdeefc484f7d53,

title = "Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?",

keywords = "Adult, Cost-Benefit Analysis, Drug Costs, Female, Fertilization in Vitro, Follicle Stimulating Hormone, Humans, Recombinant Proteins",

author = "B Ola and M Afnan and K Sharif and N Hammadieh and S Papaioannou and A Coomarasamy",

year = "2001",

month = dec,

language = "English",

volume = "80",

pages = "1141--2",

journal = "Acta obstetricia et gynecologica Scandinavica",

issn = "0001-6349",